Le Lézard
Classified in: Business, Covid-19 virus
Subjects: SVY, ECO

The Global Business Barometer improved for the second straight month, with the 3-month outlook for many industries moving from "much" to "somewhat" worse


LONDON, Aug. 6, 2020 /CNW/ -- Economic recoveries from crises such as the covid-19 pandemic come in many shapes. The hope everywhere is always that they will be V-shaped, but Us are the next best thing. Volatile Ws and the dreaded L are the worst-case scenarios. The latest Global Business Barometer, based on a survey and analysis conducted by The Economist Intelligence Unit and supported by SAS, shows that as of late June the possibility of U-shaped recovery remains possible.

 

EIU Logo

 

Ticking closer to positive: The overall barometer reading for the global economy reached -16.8, the closest it has been to positive territory yet. Respondents in Latin America and the Asia Pacific led the way, with +18.5 and +4.0 improvements respectively. Sentiment about the global and regional economies in North America barely budged from the previous barometer, rising by +1.5 and +0.2 points, making it the most pessimistic on both accounts.

China, the first economy to turn positive: The three-month outlook for the Chinese economy among China-based executives tipped into "somewhat better" in June, though only just at +2.0. This still makes it the first economy to do since the GBB began in April. The change in sentiment is in stark contrast to the last GBB when the outlook there soured by -21.9, by far the most among the twelve main economies surveyed. 

The road, less traveled:. Only 8.1% of respondents to the June GBB survey "strongly agree" that their country is ready to open and only 6.7% "strongly agree" that their company is ready to return to operating as it had done before the pandemic. Those figures are chilling whether you read them as recognition of the scale and scope of the problem or an indictment of global and country-level responses to covid-19 (or some combination of the two). For them to improve will require more leaders and policymakers around the world to demonstrate to everyone that they can be more effective in containing the virus.

About the research

The Global Business Barometer gauges sentiment towards current events and financial market uncertainty and explores how businesses are coping today and planning for the future.

About The Economist Intelligence Unit

The Economist Intelligence Unit is the thought leadership, research and analysis division of The Economist Group and the world leader in global business intelligence for executives. We uncover novel and forward-looking perspectives with access to over 650 expert analysts and editors across 200 countries worldwide. More information can be found on www.eiuperspectives.economist.com. Follow us on Twitter, LinkedIn and Facebook.

About SAS

SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

Logo - https://mma.prnewswire.com/media/805745/EIU_Logo.jpg  

 

SOURCE The Economist Intelligence Unit


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: